MEDBOT-B (02252): He Chao Appointed as Authorized Representative

MEDBOT-B (02252) announced that Dr. Chang Zhaohua (Dr. Chang) has resigned as a director of the Company (including the positions of chairman and non-executive director) with effect from the date of this announcement, as he needs to focus more on frontier technology research and scientific innovation work at the relevant companies and research institutions. Before the appointment of a new chairman, to ensure the normal operation of the Company's business management, Dr. He Chao (Dr. He), an executive director and president of the Company, will temporarily perform the duties of chairman. The board of directors further announced that with effect from the date of this announcement, Dr. Chang will cease to be the authorized representative of the Company as required under Rule 3.05 of the Listing Rules, and Dr. He, an executive director and president of the Company, will replace Dr. Chang as the authorized representative of the Company.